Roche Nears Deal to Buy Spark Therapeutics for Close to $5 Billion

Roche Holding AG RHHBY 0.51% is nearing a deal to buy Philadelphia biotechnology company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.